mefenamic acid and 5,8,11,14-eicosatetraynoic acid

mefenamic acid has been researched along with 5,8,11,14-eicosatetraynoic acid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1
Fudenberg, HH; Jonsson, HT; Smith, CL; Wilson, GB1

Other Studies

2 other study(ies) available for mefenamic acid and 5,8,11,14-eicosatetraynoic acid

ArticleYear
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016
Effects of dialyzable leukocyte extracts (DLE) with transfer factor activity on leukocyte migration in vitro. IV. Two distinct effects of DLE on leukocyte migration can be produced by prostaglandins.
    Clinical immunology and immunopathology, 1980, Volume: 16, Issue:1

    Topics: 5,8,11,14-Eicosatetraynoic Acid; Anti-Inflammatory Agents; Antigens; Cell Migration Inhibition; Dialysis; Humans; Ibuprofen; Immunity, Cellular; Indomethacin; Leukocytes; Mefenamic Acid; Molecular Weight; Neutrophils; Prostaglandins; Prostaglandins A; Prostaglandins E; Prostaglandins F; Transfer Factor; Tuberculin

1980